US 25,678,956 T7

GPTKB entity

Properties (76)
Predicate Object
gptkbp:instanceOf patent
gptkbp:hasAbstract This patent describes a novel method for treating a specific disease using a combination of compounds.
gptkbp:hasAccessibilityFeatures Positive.
gptkbp:hasApplicationNumber PCT/US2010/123456
gptkbp:hasAssignee gptkb:Pharma_Corp.
gptkbp:hasClaim 20
gptkbp:hasCollaborationsWith Collaboration_with_XYZ_Labs.
XYZ_Labs.
gptkbp:hasContent 10
gptkbp:hasContribution Lead Inventor
gptkbp:hasCountry gptkb:United_States
gptkbp:hasCPCClassification A61K 31/00
gptkbp:hasDescription The invention relates to a method for treating diseases.
gptkbp:hasDeveloped Phase II.
gptkbp:hasExaminer Jane_Smith
gptkbp:hasFacility Patent Family A
gptkbp:hasFieldOfUse medical treatment
gptkbp:hasFilingDate 2010-05-15
gptkbp:hasFunding gptkb:National_Institutes_of_Health
Venture_Capital.
gptkbp:hasImpactOn High
gptkbp:hasInventor gptkb:John_Doe
gptkbp:hasLegalStatus Active
Granted
gptkbp:hasLocalCuisine Positive.
Significant.
NCT01234567
Phase III.
gptkbp:hasMember 5
gptkbp:hasOccupation Compliant.
FDA_Approved
gptkbp:hasPartnershipsWith gptkb:Pharma_Corp.
In Development
Successful.
Collaboration_with_ABC_Inc.
Partnership_with_Pharma_Corp.
gptkbp:hasPatentNumber 25,678,956
gptkbp:hasPerformance High.
gptkbp:hasPersonnel Exclusive_License_to_Pharma_Corp.
gptkbp:hasPriorityDate 2009-05-15
2012-09-25
2030-05-15
gptkbp:hasPublications gptkb:US_2011/0123456_A1
2011-06-01
WO_2011/0123456
gptkbp:hasRecognition High.
Significant.
gptkbp:hasRelatedPatent Utility Patent
Incremental_Innovation.
US_25,678,955_T6
gptkbp:hasResearchInterest biotechnology
drug development
High.
Successful.
Conducted.
NIH_Grant.
Published_in_Journal_of_Medicine.
gptkbp:hasResidence gptkb:University_of_Science
gptkbp:hasSibling Promising.
gptkbp:hasSpecialty Patent portfolio.
Fast Track.
gptkbp:hasTechnicalField therapeutics
pharmaceutical compositions
gptkbp:hasTechnology Active.
University_Tech_Transfer
gptkbp:hasTitle Method for treating a disease
https://www.w3.org/2000/01/rdf-schema#label US 25,678,956 T7
gptkbp:isCitedBy US_25,678,957_T8
gptkbp:isFiledIn gptkb:United_States
gptkbp:isRelatedTo US_25,678,955_T6
gptkbp:market Cancer treatment
High.
Approved for clinical use.
Direct to market.
Completed.
gptkbp:provides Oncology.